National Bank of Canada’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.07K | Sell |
2,716
-2
| -0.1% | -$6 | ﹤0.01% | 2043 |
|
|
2025
Q1 | $6.12K | Sell |
2,718
-1
| -0% | -$2 | ﹤0.01% | 2023 |
|
|
2024
Q4 | $10.2K | Hold |
2,719
| – | – | ﹤0.01% | 1953 |
|
|
2024
Q3 | $8.12K | Sell |
2,719
-182
| -6% | -$544 | ﹤0.01% | 1941 |
|
|
2024
Q2 | $8.29K | Hold |
2,901
| – | – | ﹤0.01% | 2012 |
|
|
2024
Q1 | $7.97K | Hold |
2,901
| – | – | ﹤0.01% | 2024 |
|
|
2023
Q4 | $7.97K | Hold |
2,901
| – | – | ﹤0.01% | 2039 |
|
|
2023
Q3 | $8.13K | Sell |
2,901
-169
| -6% | -$474 | ﹤0.01% | 2018 |
|
|
2023
Q2 | $9.66K | Hold |
3,070
| – | – | ﹤0.01% | 2022 |
|
|
2023
Q1 | $8.39K | Hold |
3,070
| – | – | ﹤0.01% | 2045 |
|
|
2022
Q4 | $8.86K | Buy |
3,070
+2,521
| +459% | +$7.27K | ﹤0.01% | 2046 |
|
|
2022
Q3 | $2K | Sell |
549
-2,521
| -82% | -$9.18K | ﹤0.01% | 2371 |
|
|
2022
Q2 | $16K | Hold |
3,070
| – | – | ﹤0.01% | 1938 |
|
|
2022
Q1 | $22K | Buy |
3,070
+161
| +6% | +$1.15K | ﹤0.01% | 1924 |
|
|
2021
Q4 | $22K | Buy |
+2,909
| New | +$22K | ﹤0.01% | 1926 |
|